GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Nortem Biogroup (XPAR:MLBIO) » Definitions » Cash Conversion Cycle

Nortem Biogroup (XPAR:MLBIO) Cash Conversion Cycle : 1,829.94 (As of Dec. 2022)


View and export this data going back to 2023. Start your Free Trial

What is Nortem Biogroup Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Nortem Biogroup's Days Sales Outstanding for the six months ended in Dec. 2022 was 60.24.
Nortem Biogroup's Days Inventory for the six months ended in Dec. 2022 was 2035.15.
Nortem Biogroup's Days Payable for the six months ended in Dec. 2022 was 265.45.
Therefore, Nortem Biogroup's Cash Conversion Cycle (CCC) for the six months ended in Dec. 2022 was 1,829.94.


Nortem Biogroup Cash Conversion Cycle Historical Data

The historical data trend for Nortem Biogroup's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nortem Biogroup Cash Conversion Cycle Chart

Nortem Biogroup Annual Data
Trend Dec21 Dec22
Cash Conversion Cycle
603.04 1,829.94

Nortem Biogroup Semi-Annual Data
Dec21 Dec22
Cash Conversion Cycle 603.04 1,829.94

Competitive Comparison of Nortem Biogroup's Cash Conversion Cycle

For the Packaged Foods subindustry, Nortem Biogroup's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nortem Biogroup's Cash Conversion Cycle Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Nortem Biogroup's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Nortem Biogroup's Cash Conversion Cycle falls into.



Nortem Biogroup Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Nortem Biogroup's Cash Conversion Cycle for the fiscal year that ended in Dec. 2022 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=60.24+2035.15-265.45
=1,829.94

Nortem Biogroup's Cash Conversion Cycle for the quarter that ended in Dec. 2022 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=60.24+2035.15-265.45
=1,829.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nortem Biogroup  (XPAR:MLBIO) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Nortem Biogroup Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of Nortem Biogroup's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


Nortem Biogroup (XPAR:MLBIO) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Calle Alexander Humboldt 12B, Polígono Industrial Salinas de Poniente, El Puerto de Santa María, Cadiz, ESP, 11500
Nortem Chem SA is engaged in the research, development, innovation and industrialization in the field of biochemistry and biotechnology, as well as the production and sale of products based on biochemical and/or biotechnological processes. It emerged as a biotechnological company in the field of the food and chemical industry, with maximum environmental awareness, concentrating its research and product development efforts on the development of environmentally friendly alternatives from renewable sources and obtaining its own microorganisms (Aspergillus Niger and Yarrowia lipolytica) with outstanding capabilities from adaptation and selection processes, avoiding the use of genetic modification technologies.

Nortem Biogroup (XPAR:MLBIO) Headlines

No Headlines